The selective 5-HT6 receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801

Behavioural Brain Research

Volumn 188, Issue 2, 2008, Pages 304-309

  Pitsikas, Nikolaos ^a   Zisopoulou, Styliani ^a   Pappas, Ioannis ^a   Sakellaridis, Nikolaos ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

5 HT6 receptor; Ataxia; MK 801; Motility; Recognition memory; Ro 04 6790; Stereotypies

Indexed keywords

4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEROTONIN 6 RECEPTOR;

AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATAXIA; CAGE; CONTROLLED STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPERACTIVITY; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION; SCHIZOPHRENIA; STEREOTYPY; SYMPTOM;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXPLORATORY BEHAVIOR; MALE; MENTAL DISORDERS; MOTOR ACTIVITY; PATTERN RECOGNITION, VISUAL; PYRIMIDINES; RATS; RATS, WISTAR; SEROTONIN ANTAGONISTS;

EID: 39149098130     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.11.010     Document Type: Article

References (36)

1. Andine P., Widermark N., Axelsson R., Nyberg G., Olofsson U., Martensson E., et al. Characterization of MK-801-induced behavior as putative rat model of psychosis. J Pharmacol Exp Ther 290 (1999) 1393-1408
2. 6 receptor antagonist, Ro 04-6790, in rats. Br J Pharmacol 126 (1999) 1537-1542
3. Bowie C.R., and Jaga K. Methods for treating cognitive deficits in schizophrenia. Expert Rev Neurother 7 (2007) 281-287
4. Breese G.R., Knapp D.J., and Moy S.S. Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug action on NMDA antagonist responsiveness. Neurosci Biobehav Rev (2002) 441-455
5. Carlsson M.L. Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways?. J Neural Transm 94 (1993) 1-10
6. Cavoy A., and Delacour J. Spatial but not object recognition is impaired by aging in rats. Physiol Behav 53 (1993) 527-530
7. 6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25 (2001) 662-668
8. De Lima M.N.M., Laranja D.C., Bromberg E., Roesler R., and Schroder N. Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats. Behav Brain Res 156 (2005) 139-143
9. East S.Z., Burnet P.W., Kerwin R.W., and Harrison P.J. An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. Schizophr Res 57 (2002) 15-26
10. Ennaceur A., and Delacour J. A new one-trial test for neurobiological studies of memory in rats. I. Behavioral data. Behav Brain Res 31 (1988) 47-59
11. Freund T.F., Gulyas A.I., Acsady L., Gores T., and Toth K. Serotonergic control of the hippocampus via local inhibitory interneurones. Proc Natl Acad Sci USA 87 (1990) 8501-8505
12. 6 receptor-like material in the rat central nervous system. Brain Res 746 (1997) 207-219
13. Gray J.A., and Roth B.L. The pipeline and future of drug development in schizophrenia. Mol Psychiatry 12 (2007) 904-922
14. 6 receptors. Neuropsychopharmacology 21 (1999) 68S-76S
15. 7 mRNA expression in rat brain. Neuropsychopharmacology 21 (1999) 341-351
16. Hirsch S.R., Das I., Garey L.J., and de Belloeroche J. A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction. Pharmacol Biochem Behav 56 (1997) 797-802
17. Javitt D.C., and Zukin R.S. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148 (1991) 1301-1308
18. 6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation-an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47 (2004) 195-204
19. 6 serotonin receptor. J Neurochem 66 (1996) 47-56
20. 6 receptor antagonists Ro 04-6790 and Ro 65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine. Pharmacol Biochem Behav 75 (2003) 281-288
21. Martin P., Carlsson M.L., and Hjorth S. Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. Neuroreport 9 (1998) 2985-2988
22. 6 receptor antagonist Ro 04-6790 on learning consolidation. Behav Brain Res 118 (2001) 107-110
23. 6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 108 (2005) 320-333
24. Monsma F.J., Shen Y., Ward R.P., Hamlin M.W., and Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 43 (1993) 320-327
25. Ogren S.O., and Goldstein M. Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology 11 (1994) 167-177
26. 6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task. Pharmacol Biochem Behav 81 (2005) 673-682
27. Pitsikas N., Zisopoulou S., and Sakellaridis N. Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801. J Neurosci Res 84 (2006) 299-305
28. 6 receptor antagonist, SB-271046, in animal models for schizophrenia. Pharmacol Biochem Behav 71 (2002) 635-643
29. 7 receptors. J Pharmacol Exp Ther 268 (1994) 1403-1410
30. 6 receptor antagonist. Br J Pharmacol 130 (2000) 1606-1612
31. Schreiber R., Vivian J., Headley L., Szczepanski K., Secchi R.L., Zuzov M., et al. Effects of the novel 5-HT(6) receptor antagonist Ro4368554 in rat models for cognition and sensorimotor gating. Eur Neuropsychopharmacol 17 (2007) 277-288
32. 6 receptors. Br J Pharmacol 124 (1998) 556-562
33. Tricklebank M.D., Singh L., Oles R.J., Preston C., and Iversen S.D. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167 (1989) 127-135
34. Verma A., and Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16 (1996) 373-379
35. Willetts J., Balster R.L., and Leander J.D. The behavioural pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11 (1993) 423-428
36. 6 receptor antagonist, Ro-046790. Psychopharmacology 170 (2003) 358-367